Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Addressing high dose AAV toxicity – ‘one and done’ or ‘slower and lower’?
Takashi Kishimoto, R. Jude Samulski
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 9, pp. 1067-1071
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Immunogenicity and toxicity of AAV gene therapy
Hildegund C.J. Ertl
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 183
Efficient prime editing in mouse brain, liver and heart with dual AAVs
Jessie R. Davis, Samagya Banskota, Jonathan M. Levy, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 2, pp. 253-264
Open Access | Times Cited: 113
Viral Vector-Based Gene Therapy
Xuedan Li, Yang Le, Zhegang Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7736-7736
Open Access | Times Cited: 98
AAV-based in vivo gene therapy for neurological disorders
Qinglan Ling, Jessica A. Herstine, Allison M. Bradbury, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 789-806
Closed Access | Times Cited: 92
rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
Weiran Shen, Shengjiang Liu, Li Ou
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 87
Drug delivery systems for CRISPR-based genome editors
Victoria J. Madigan, Feng Zhang, James E. Dahlman
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 11, pp. 875-894
Closed Access | Times Cited: 76
Evolution of nanomedicine formulations for targeted delivery and controlled release
Sanyogitta Puri, Mariarosa Mazza, Gourgopal Roy, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114962-114962
Closed Access | Times Cited: 49
Lethal immunotoxicity in high-dose systemic AAV therapy
Dongsheng Duan
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3123-3126
Open Access | Times Cited: 49
Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy
Martin Schulz, David Lévy, Christos J. Petropoulos, et al.
Molecular Therapy (2023) Vol. 31, Iss. 3, pp. 616-630
Open Access | Times Cited: 47
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry
Laurent Servais, John Day, Darryl C. De Vivo, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 425-442
Open Access | Times Cited: 26
Analytical characterization of full, intermediate, and empty AAV capsids
Aisleen McColl-Carboni, Serena Dollive, Sarah Laughlin, et al.
Gene Therapy (2024) Vol. 31, Iss. 5-6, pp. 285-294
Open Access | Times Cited: 26
Gene therapy for CNS disorders: modalities, delivery and translational challenges
Jingjing Gao, Swetharajan Gunasekar, Ziting Xia, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 8, pp. 553-572
Closed Access | Times Cited: 21
Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care
Marian L. Henderson, Jacob K. Zieba, Xiaopeng Li, et al.
BioTech (2024) Vol. 13, Iss. 1, pp. 1-1
Open Access | Times Cited: 18
Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
Tong‐Yuan Yang, Manuela Braun, Wibke Lembke, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 26, pp. 471-494
Open Access | Times Cited: 49
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
Corinne J. Smith, Nikki L. Ross, Ali Kamal, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Evading and overcoming AAV neutralization in gene therapy
Joseph Earley, Elena Piletska, Giuseppe Ronzitti, et al.
Trends in biotechnology (2022) Vol. 41, Iss. 6, pp. 836-845
Open Access | Times Cited: 39
Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’
Angela Lek, Evrim Atas, Sharon Hesterlee, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 3, pp. 327-336
Open Access | Times Cited: 28
Engineering viral vectors for acoustically targeted gene delivery
Hongyi Li, Manwal Harb, John E. Heath, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation
Marti Cabanes‐Creus, Sophia H.Y. Liao, Renina Gale Navarro, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Innate Immune Sensing of AAV Vectors
Di Cao, Barry J. Byrne, Ype P. de Jong, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 13-14, pp. 451-463
Closed Access | Times Cited: 10
Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects
Żaneta Słyk, Natalia Stachowiak, Maciej Małecki
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1523-1523
Open Access | Times Cited: 9
Adeno-Associated Viruses as Gene Delivery Tools for Diabetic Heart Disease and Failure: Key Considerations for Clinicians and Preclinical Researchers
Kate L. Weeks, Bianca C. Bernardo
Heart Lung and Circulation (2025)
Open Access | Times Cited: 1
A brief guide for gene delivery to the brain using adeno-associated viral vectors
Seungwan Han, Eun Mo Yang, Eun‐Mi Hur
Molecules and Cells (2025), pp. 100189-100189
Open Access | Times Cited: 1
A two-pass anion exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors
Garima Thakur, Sheldon Mink, A García, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 2, pp. 101441-101441
Open Access | Times Cited: 1
Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies
Tamara Burdett, Samir Nuseibeh
Gene Therapy (2022) Vol. 30, Iss. 3-4, pp. 323-335
Closed Access | Times Cited: 36
Page 1 - Next Page

Scroll to top